Trichotillomania: a good response to treatment with N-acetylcysteine

An Bras Dermatol. 2017 Jul-Aug;92(4):537-539. doi: 10.1590/abd1806-4841.20175435.

Abstract

Trichotillomania is considered a behavioral disorder and is characterized by the recurring habit of pulling one's hair, resulting in secondary alopecia. It affects 1% of the adult population, and 2 to 4.4% of psychiatric patients meet the diagnostic criteria. It can occur at any age and is more prevalent in adolescents and females. Its occurrence in childhood is not uncommon and tends to have a more favorable clinical course. The scalp, eyebrows and eyelashes are the most commonly affected sites. Glutamate modulating agents, such as N-acetylcysteine, have been shown to be a promising treatment. N-acetylcysteine acts by reducing oxidative stress and normalizing glutaminergic transmission. In this paper, we report a case of trichotillomania with an excellent response to N-acetylcysteine.

Publication types

  • Case Reports

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Alopecia / diagnosis
  • Alopecia / etiology
  • Antioxidants / therapeutic use*
  • Child
  • Diagnosis, Differential
  • Humans
  • Male
  • Trichotillomania / diagnosis
  • Trichotillomania / drug therapy*

Substances

  • Antioxidants
  • Acetylcysteine